Long-term safety study of gene modified T cell treatment
Part of Cancer, Immune system & allergy clinical trials.
This study is a long-term safety check for people who have already received a gene modified T cell treatment in a previous study sponsored by 2seventy bio or Regeneron Pharmaceuticals. The goal is to monitor your health for years after that treatment to see how well it works and if any side effects appear over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received at least one infusion of gene modified T cells in a past study sponsored by 2seventy bio (before April 2024) or Regeneron Pharmaceuticals.
- You must have completed the full follow-up period of that earlier study, or at least 6 months of safety monitoring if you stopped early.
- You and/or your legal representative must agree to and sign a consent form to be in this long-term follow-up study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term check-in for people who previously received gene-modified T-cell infusions in a related Celgene/Juno/BMS trial. It helps researchers track safety and long-term effects over time.
This study checks your health over time after you previously received gene-modified cell therapy in a Sorrento-sponsored trial. It helps researchers understand long-term safety and outcomes and may lead to better care for future patients.
This is a long-term follow-up study for people who have already received gene-modified T-cell therapy. It observes your health over time to see how well the treatment worked and any long-term effects.
This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.
This study checks long-term health after receiving a gene-modified cell therapy through a St. Jude study. It helps doctors understand the treatment’s lasting effects and safety over time.
This study follows patients who received gene therapy at Seattle Children's Hospital to check on their health and safety over time. It helps doctors understand how well the treatment works in the long run.
Hear when a new Long Term Safety Following GM T Cell Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.